Active, not recruitingPhase 1NCT01961063
Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
Studying Plasmablastic lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- City of Hope Medical Center
- Principal Investigator
- Amrita KrishnanCity of Hope Medical Center
- Intervention
- busulfan(drug)
- Enrollment
- 3 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2015 – 2026
Study locations (1)
- City of Hope Medical Center, Duarte, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01961063 on ClinicalTrials.govOther trials for Plasmablastic lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06781359Study on Plasmablastic Lymphoma PatientsFondazione Italiana Linfomi - ETS
- RECRUITINGPHASE2NCT04915248Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.Fondazione Italiana Linfomi - ETS
- RECRUITINGEARLY PHASE1NCT04139304A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaAIDS Malignancy Consortium